Mycardium AI Limited

Mycardium AI Limited has 2 AI-enabled medical devices on the FDA list. The first decision was on November 15, 2024 and the most recent on June 30, 2025 (EchoConfidence (USA)). Its most common review panel is Radiology (2 devices).